adverse event terminology and
play

Adverse Event Terminology and Coding Working Group Sept 2017 - PowerPoint PPT Presentation

Apr 11, 2024 •344 likes •478 views

Adverse Event Terminology and Coding Working Group Sept 2017 Working Group Chair: H. Ishikawa Office of Standards and Guidelines Development Pharmaceuticals and Medical Devices Agency Member list Australia: TGA Japan: PMDA Pamela Carter

  1. Adverse Event Terminology and Coding Working Group Sept 2017 Working Group Chair: H. Ishikawa Office of Standards and Guidelines Development Pharmaceuticals and Medical Devices Agency

  2. Member list Australia: TGA Japan: PMDA Pamela Carter Hiroshi Ishikawa (Chair) Jorge Garcia Mari Shirotani Brazil: ANVISA Tsutomu Makino Maria Gloria Vicente Madoka Murakami Adriana Moufarrege Miho Sato Guilherme Antonio Marques Buss Takako Niwa Canada: Health Canada Kaori Ogawa Mary Raphael MHLW European Union: Miki Oota Jean-François Roche (EC) Noriaki Tokunaga Tony Sant (UK, MHRA) US: FDA Claudius Griesinger (EC/JRC) Nancy Pressly Graham Nash (UK, MHRA) Evan Jacobs Tim Raemaekers (EC/JRC) Singapore: HSA Robin Seidel (BfArM) Wong Woei Jiuang Russia: Roszdravnadzor AHWP: Aysylu Valeeva Sasikala Devi Thangavelu Elena Astapenko Gulnar Berkimbayeva 2 WHO: Anita Sands Nursultan Kalamov

  3. Recent Meetings • Apr 5 th , 2017 16 th Teleconference • June 13 th – 16 th , 2017 4 th Face to Face meeting in Ispra, Italy • July 6 th , 2017 17 th Teleconference Coming Meetings • Oct 11 th , 2017 18 th Teleconference • Nov 28 th – Dec 1 st , 2017 5 th Face to Face meeting in Moscow, Russia 3

  4. Adverse Event Reporting PATIENT DEVICE/COMPONENTS Medical Device Component Problem (Annex F) (Annex A) What was the problem Which components Patient at device level? were involved Problem (Annex E) What were the probable causes of the problem Cause What adverse Investigation events happened (Annex B-D) at patient level 4

  5. Title: IMDRF terminologies for categorized Adverse Event Reporting (AER): terms, terminology structure and codes Annex F Annex E Annex B - D Annex A Main Body: published on April 10 th in 2017 revised with the addition of Annexes Main Body B, C and D, and presented to MC as proposed final document (Edition 2) Annex A (Medical Device Problem): published with mapping on April 10 th in 2017 Annex B – D (Cause Investigation): presented to MC as proposed final document Annex E (Patient Problem): under discussion Annex F (Component): to be discussed after Annex E takes shape 5

  6. Annex B-D: Cause Investigation Terms and Codes • Based on FDA terms and ISO terms • Consist of IMDRF codes, terms and definitions • 3 annexes Annex B: Type of Investigation (1 level) (e.g., Testing of Actual/Suspected Device, Testing of Device from Same Lot/Batch, Trend Analysis) Annex C: Investigation Findings (3 levels) (e.g., Biological Problem Identified, Cytotoxicity Problem Identified, Microbial Contamination) Annex D: Investigation Conclusion (2 levels) (e.g., Cause Traced to Device Design, Cause Traced to Manufacturing, Quality Control Deficiency) 6

  7. Annex B: Type of Investigation 7

  8. Annex C: Investigation Findings 8

  9. Annex D: Investigation Conclusion 9

  10. Annex E : Patient Problem • Based on FDA terms and refers to MedDRA • Consists of IMDRF codes, terms and definitions • JRC contributed the results of their own research on “the patient problem nomenclatures” at F2F in Ispra, and now organizing the structure of Annex E with mapping to MedDRA terms • Communicating with MedDRA, SNOMED and ICD closely 10

  11. 2017 Work Plan (as of July 2017) 2017 2018 Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep MC f2f MC TC MC f2f MC TC MC f2f Medical Device Problem MC approval WG f2f WG f2f FD Publish Moscow Cause Investigation MC approval FD Publish MC review Patient Problem Public Consultation MC review Components Public Consultation Maintenance phase Deadline

  12. Thank you! 12

Recommend

Development of common terminology and code related to adverse event of medical device - NWIP

Development of common terminology and code related to adverse event of medical device - NWIP

Development of common terminology and code related to adverse event of medical device - NWIP September, 2014 Purpose and goal Common terminology and code related to adverse event of medical device will developed. 2 Expectation

159 views • 5 slides
Adverse Event Terminology and Coding Working Group Sep 2018 Working Group Chair: H. Ishikawa

Adverse Event Terminology and Coding Working Group Sep 2018 Working Group Chair: H. Ishikawa

Adverse Event Terminology and Coding Working Group Sep 2018 Working Group Chair: H. Ishikawa Office of Standards and Guidelines Development Pharmaceuticals and Medical Devices Agency 1 Overview of IMDRF AE WG NWIP Initial submission:

636 views • 14 slides
Adverse Event Terminology and Coding Working Group March 9 2016 H. Ishikawa Office of Standards

Adverse Event Terminology and Coding Working Group March 9 2016 H. Ishikawa Office of Standards

Adverse Event Terminology and Coding Working Group March 9 2016 H. Ishikawa Office of Standards and Guidelines Development Pharmaceuticals and Medical Devices Agency WG Member Australia: TGA Japan: PMDA Pamela Carter Hiroshi Ishikawa

478 views • 10 slides
Adverse Event Terminology and Coding Working Group March 2017 Working Group Chair: H. Ishikawa

Adverse Event Terminology and Coding Working Group March 2017 Working Group Chair: H. Ishikawa

Adverse Event Terminology and Coding Working Group March 2017 Working Group Chair: H. Ishikawa Office of Standards and Guidelines Development Pharmaceuticals and Medical Devices Agency Member list Australia: TGA Japan: PMDA Pamela Carter

180 views • 14 slides
Adverse Event Terminology and Coding Working Group March 2018 Working Group Chair: H. Ishikawa

Adverse Event Terminology and Coding Working Group March 2018 Working Group Chair: H. Ishikawa

Adverse Event Terminology and Coding Working Group March 2018 Working Group Chair: H. Ishikawa Office of Standards and Guidelines Development Pharmaceuticals and Medical Devices Agency Overview of IMDRF AE WG NWIP Initial submission:

416 views • 14 slides
Adverse Event Terminology and Coding Working Group March 2019 Working Group Chair: H. Ishikawa

Adverse Event Terminology and Coding Working Group March 2019 Working Group Chair: H. Ishikawa

Adverse Event Terminology and Coding Working Group March 2019 Working Group Chair: H. Ishikawa Office of Standards and Compliance for Medical Devices Pharmaceuticals and Medical Devices Agency Overview of IMDRF AE WG NWIP Initial submission:

276 views • 15 slides
http://finance.practicallaw.com/4-524-0432 14/02/2013 PLC - Material adverse change event

http://finance.practicallaw.com/4-524-0432 14/02/2013 PLC - Material adverse change event

PLC - Material adverse change event established and appropriation not i... Page 1 of 9 Material adverse change event established and appropriation not invalid but relief from forfeiture available (Privy Council) Resource type: Legal update: case

227 views • 9 slides
Adverse Event Reporting at ClinicalTrials.gov Deborah A. Zarin , M.D. Director,

Adverse Event Reporting at ClinicalTrials.gov Deborah A. Zarin , M.D. Director,

Adverse Event Reporting at ClinicalTrials.gov Deborah A. Zarin , M.D. Director, ClinicalTrials.gov National Library of Medicine/NIH November 2010 1 Adverse Event Reporting under FDAAA FDAAA Title VIII covers certain clinical trials of

424 views • 10 slides
AE Toxicity Grading for Why do we care????? Transplant Patients Toxicity vs Adverse

AE Toxicity Grading for Why do we care????? Transplant Patients Toxicity vs Adverse

Objectives AE Toxicity Grading for Why do we care????? Transplant Patients Toxicity vs Adverse Event vs Serious Adverse Event Marcie Tomblyn, MD, MS Importance of accurate toxicity grading Associate Member Director, BMT Clinical

69 views • 5 slides
Intel Terminology Interrupt Asynchronous event, typically triggered by an I/O device

Intel Terminology Interrupt Asynchronous event, typically triggered by an I/O device

Intel Terminology Interrupt Asynchronous event, typically triggered by an I/O device Eventually resumes at next instruction Hardware Level Exceptional Control Flow; Exception Again Synchronous event, triggered by the

302 views • 3 slides
PRO CTCAEs The 2017 update PROs: context Usual description of adverse events with the

PRO CTCAEs The 2017 update PROs: context Usual description of adverse events with the

PRO CTCAEs The 2017 update PROs: context Usual description of adverse events with the 790-items CTCAE (Common Terminology of Adverse Events) criteria under-detects symptomatic, though significant events Patients reports better

521 views • 9 slides
FDA Regulations v. Product Liability Law: Cleaning Up After an Adverse Event Medmarc Webinar

FDA Regulations v. Product Liability Law: Cleaning Up After an Adverse Event Medmarc Webinar

FDA Regulations v. Product Liability Law: Cleaning Up After an Adverse Event Medmarc Webinar August 27, 2015 Beth S. Rose, Esq. Member (973) 643-5877 | brose@sillscummis.com One Riverfront Plaza Newark, NJ 07102 0 | FDA Regulations v.

433 views • 32 slides
How do we know vaccines are safe ? Safety inferred because of an absence of adverse reactions

How do we know vaccines are safe ? Safety inferred because of an absence of adverse reactions

How do we know vaccines are safe ? Safety inferred because of an absence of adverse reactions We detect Adverse Events Following Immunisation Then perform cause specific classification to differentiate an event which is a reaction from a

1.34k views • 91 slides
Adverse event cluster analysis for syndromic surveillance G.N.

Adverse event cluster analysis for syndromic surveillance G.N.

Adverse event cluster analysis for syndromic surveillance G.N. Norn, J. Fransson, K. Juhlin, R. Chandler, I.R. Edwards Background Syndromic surveillance is

499 views • 26 slides
M&M Discussion Framework Knowledge System Practice Adverse Event Communication Context

M&M Discussion Framework Knowledge System Practice Adverse Event Communication Context

M&M Discussion Framework Knowledge System Practice Adverse Event Communication Context Other EX: Sepsis Mortality Equipment Process People - EMR does not provide - Time to antibiotics - Staffing in ED SIRS alerts - Enough fluid

994 views • 77 slides
Network analysis of possible anaphylaxis cases reported to the US Vaccine Adverse Event Reporting

Network analysis of possible anaphylaxis cases reported to the US Vaccine Adverse Event Reporting

Network analysis of possible anaphylaxis cases reported to the US Vaccine Adverse Event Reporting System after H1N1 influenza vaccine Taxiarchis Botsis 1,2 & Robert Ball 1 1 Center for Biologics Evaluation and Research (CBER), U.S. Food and

384 views • 11 slides
Update on the Adverse Event Management System and Electronic Data Interchange Bernadette Barton,

Update on the Adverse Event Management System and Electronic Data Interchange Bernadette Barton,

Update on the Adverse Event Management System and Electronic Data Interchange Bernadette Barton, Claire Larter, Iga Policinska and Warren Arndt Pharmacovigilance and Special Access Branch, Medicine Regulation Division, TGA Australian

590 views • 21 slides
COMMONLY USED ABBREVIATIONS AND TERMS in CLINCAL TRIALS Abbreviation Definition ADR Adverse Drug

COMMONLY USED ABBREVIATIONS AND TERMS in CLINCAL TRIALS Abbreviation Definition ADR Adverse Drug

COMMONLY USED ABBREVIATIONS AND TERMS in CLINCAL TRIALS Abbreviation Definition ADR Adverse Drug Reaction AE Adverse Event AUC Area Under the Curve BLA Biologic Licensing Application BUN Blood Urea Nitrogen CAP College of American

157 views • 3 slides
Adverse event reporting in pigs Ken Steen Pedersen www.oevet.dk -VET A/S -Vet A/S was

Adverse event reporting in pigs Ken Steen Pedersen www.oevet.dk -VET A/S -Vet A/S was

Adverse event reporting in pigs Ken Steen Pedersen www.oevet.dk -VET A/S -Vet A/S was founded in 1996 and today consists of 15 people www.oevet.dk -Vet A/S Farms visited regulary Farms visited ocasionally www.oevet.dk Veterinarian

238 views • 10 slides
US Health Care Professional Perspectives on Adverse Drug Event Reporting in the Hospital Setting

US Health Care Professional Perspectives on Adverse Drug Event Reporting in the Hospital Setting

US Health Care Professional Perspectives on Adverse Drug Event Reporting in the Hospital Setting and the Opportunity for Information Technology Gustavo Grampp Amgen Inc. ! Stella Stergiopoulos, Tufts CSDD; Carrie A. Brown, Tufts University;

269 views • 14 slides
Client Alert FDA Issues Draft Guidance on Postmarketing Adverse Event Reporting Contact Attorneys

Client Alert FDA Issues Draft Guidance on Postmarketing Adverse Event Reporting Contact Attorneys

Client Alert FDA Issues Draft Guidance on Postmarketing Adverse Event Reporting Contact Attorneys Regarding for Nonprescription Human Drug Products Marketed Without an Ap- This Matter: proved Application Alan G. Minsk INtRoDuctIoN

371 views • 4 slides
Disclosure of Adverse Jane McKay Events Adverse Events Adverse events will happen through

Disclosure of Adverse Jane McKay Events Adverse Events Adverse events will happen through

Disclosure of Adverse Jane McKay Events Adverse Events Adverse events will happen through out your medical career . You must be able to discuss this with your patients . Lets outline a strategy to do this Disclosure of Adverse Events

444 views • 17 slides
Medical Devices: how to stay included Adverse event reporting and all it entails Sharon Bennett

Medical Devices: how to stay included Adverse event reporting and all it entails Sharon Bennett

Medical Devices: how to stay included Adverse event reporting and all it entails Sharon Bennett IRIS Coordinator Medical Devices Branch Therapeutic Goods Administration Learning outcomes It is envisaged at the end of this session you will be

547 views • 25 slides
Why Adverse Childhood Experiences are so Adverse: The Emerging Field of Behavioral Epigenetics

Why Adverse Childhood Experiences are so Adverse: The Emerging Field of Behavioral Epigenetics

Why Adverse Childhood Experiences are so Adverse: The Emerging Field of Behavioral Epigenetics Mark Erickson, MD Psychiatrist and Director of Tele-Behavioral Health, Alaska Psychiatric Institute; Assistant Clinical Professor of Psychiatry,

168 views • 6 slides

More recommend